Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB)

CUSIP: 984241109

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
45,101,565
Total 13F shares
8,480,229
Share change
-207,251
Total reported value
$222,267,926
Price per share
$26.21
Number of holders
44
Value change
-$3,116,524
Number of buys
18
Number of sells
18

Security key

984241109

Report period

Q1 2019

Institutions

44

Top holders

10

Ownership snapshot

Top shareholders of YMAB - Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with the largest verified stakes, then open the linked filing trail.

Lead holder
13D/G signal
Evidence rows
0
Latest as of
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q1 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
44
Shares
8,480,229
Rows loaded
44
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2019 vs Q4 2018 Across Filers

Q4 2018 holders
42
Q1 2019 holders
44
Holder diff
2
Investor Q4 2018 Shares Q1 2019 Shares Share Diff Share Chg % Q4 2018 Value $ Q1 2019 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .